arch43

EN_01454483_0436

caption

A volunteer in Oxford, England, on Friday, Nov. 20, 2020, receives the coronavirus vaccine made by AstraZeneca and the University of Oxford. The drug maker AstraZeneca announced on Monday, Nov. 23, 2020, that an early analysis of some of its late-stage clinical trials showed that its coronavirus vaccine was 70.4 percent effective, on average, in preventing COVID-19. (Andrew Testa/The New York Times)

special instructions

MINIMALNA CENA 100USD!!!

headline arch43

created date 2020-11-20

credit ANDREW TESTA/The New York Times Agency/East News

source The New York Times Agency

byline ANDREW TESTA

original transmission reference 15451302

weight 6,95MB

size 53cm x 35cm przy 300dpi

keywords - Pokaż

19, 20, 2020, 23, 4, 70, A, AN, ANALYSIS, AND, ANDREW, ANNOUNCED, ASTRAZENECA, AVERAGE, BY, CLINICAL, CORONAVIRUS, COVID, COVID-19, DRUG, EARLY, EFFECTIVE, ENGLAND, EUROPE, FRIDAY, IN, ITS, LATE-STAGE, MADE, MAKER, MONDAY, NEW, NOV, OF, ON, OXFORD, PANDEMIC, PERCENT, PREVENTING, RECEIVES, RESEARCH, SHOWED, SOME, TESTA, THAT, THE, TIMES, TRIALS, UNIVERSITY, VACCINATION, VACCINE, VOLUNTEER, WAS, YORK,